Pharma Talks

Epizode

• 
  AI in Pharma Omnichannel: From Strategy to Execution l Pharma Talks with Nataliya Andreychuk l Part 2 05.08.2026 21min

  Part 2 of this Pharma Talks conversation with Matteo Colonna picks up where strategy meets execution — moving from the "why" of omnichannel and AI to the practical realities of making it work inside pharma organizations.📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Matteo Colonna → https://www.linkedin.com/in/colonnamatteo/
• 
  AI in Pharma Omnichannel: From Strategy to Execution l Pharma Talks with Nataliya Andreychuk l Part 1 30.07.2026 18min

  Matteo Colonna, an omnichannel transformation practitioner with a background in theoretical physics from Sapienza University in Rome and experience across consulting, digital agencies, and two major pharma companies, joins Nataliya Andreychuk on Pharma Talks to unpack why omnichannel and AI have moved from "nice to have" to business necessity.Key takeaways:Customer behavior and expectations have fundamentally shifted — pharma companies can no longer design omnichannel experiences without first understanding what customers actually need and prefer.Technology should never be the starting point — the right approach begins with identifying the business or customer problem, then working backward to the technology that solves it.Omnichannel and AI transformation is no longer a technology project — it's a full business transformation that touches strategy, structure, and mindset.Real omnichannel execution requires bridging strategy and day-to-day operations, not just designing frameworks on paper.Explore how pharma teams move from omnichannel strategies to execution and where AI creates real value across content, insights, and engagement.📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Matteo Colonna → https://www.linkedin.com/in/colonnamatteo/
• 
  The Impact of AI on Jobs l Pharma Talks with Nataliya Andreychuk 22.07.2026 15min

  Karol Wolak, Director and Global Omnichannel Excellence Lead at Merck, joins Nataliya Andreychuk on Pharma Talks to tackle a question on everyone's mind: is AI coming for pharma jobs? His perspective is grounded in hands-on work across customer engagement and digital transformation at one of the industry's largest organizations.Views shared are Karol Wolak's own and do not represent an official position of Merck.Key takeaways:AI isn't replacing pharma roles anytime soon — it's better positioned to absorb repetitive back-office work like content tagging, MLR approval, and data collection.Human qualities — context, ethics, judgment, empathy — remain outside what AI can deliver, especially in a highly regulated industry.The environmental cost of AI, from data storage to energy consumption, is a factor the industry rarely puts on the table.Patient-centricity stays the anchor point for every engagement decision, regardless of which technology sits behind it.Staying engaged and experimenting with AI beats waiting on the sidelines — but balance matters more than volume.Chapters: 0:00 Cold open — "AI will not replace us, at least not now" 0:51 Karol Wolak on the shift from multichannel to omnichannel at Merck 1:49 Why patients are the real center of pharma engagement 3:33 Does AI take our jobs? The blunt answer 5:02 Resource optimization: where AI actually helps pharma teams 7:14 The environmental cost of AI no one talks about 9:18 Finding the balance between innovation and human survival 13:06 Advice for listeners: don't wait on the sidelines📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Karol Wolak → https://www.linkedin.com/in/karolwolak/
• 
  Agentic AI in Pharma: Are We Ready for AI That Acts? l Pharma Talks with Nataliya Andreychuk 17.07.2026 24min

  Agentic AI has moved pharma from answering questions to autonomously orchestrating entire workflows — but most organisations are still building the foundations it needs to run well. In this episode, Nataliya Andreychuk talks with Michal Dojlidko about what agentic AI actually requires in practice: the right data, the right guardrails, continuous upskilling, and a clear-eyed view of where humans still belong in the loop.Key topicsEvolution of AI in pharma from answering questions to autonomous workflowsImportance of trust and data foundations in AI adoptionRegulatory considerations and human oversight in agentic AIFuture roles of humans as strategists and overseers of AITechnological advancements enabling secure, scalable AI solutionsChapters00:00 Introduction to Agentic AI in Pharma Marketing00:55 Evolution of AI in Pharma02:34 The Shift to Autonomous AI03:49 Reimagining Workflows with AI05:10 Building Trust in AI06:23 Data Foundations for AI Success07:47 Continuous Learning and AI Literacy09:31 The Future Role of Humans in AI12:19 Security and Compliance in AI14:11 Human Oversight in Regulated Industries15:56 Hot or Not: AI Statements23:45 Conclusion and Key TakeawaysDiscover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/***Follow Viseven, Nataliya, and Michal in social media:https://www.linkedin.com/company/2907491https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/mdojlidko/
• 
  How to Build an Omnichannel Strategy in Pharma l Pharma Talks with Nataliya Andreychuk 08.07.2026 40min

  Michael Kirzhner, Omnichannel Platforms and Capabilities Leader at AbbVie, joins Nataliya Andreychuk to discuss the real state of omnichannel in pharma — what the industry has built, what's still missing, and where the next evolution lies.Michael has spent over a decade navigating the shift from field-centric models to digital-first orchestration inside one of the world's largest pharma companies.In this episode:Omnichannel fragmentation starts with departments, not technology — the coordination layer is what pharma hasn't built yetMost companies are strong at functional execution but lack a central decisioning function that cuts across channelsDigital opinion leaders are outpacing traditional KOLs because they've mastered the channels pharma is still learningPatient services is facing the same orchestration challenge commercial solved — and the stakes are higherAI's real value isn't automation — it's closing the gaps in personalization, decisioning, and content throughput that were previously impossible at scale📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect:🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙 Michael Kirzhner → https://www.linkedin.com/in/michaelkirzhner/
• 
  Pharma Talks with Nataliya Andreychuk | Live from NEXT Pharma Summit | Jennifer Cleall 02.07.2026 5min

  In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Jennifer Cleall, Global Head of Digital Transformation at Ferring Pharmaceuticals, on what it actually takes to align medical and commercial teams — and where AI fits into that picture.Jennifer brings cross-industry perspective spanning pharma, med tech, and enterprise technology.Key takeaways:AI won't take our jobs — but being deliberate about where and why you apply it is what separates progress from noiseBefore layering in AI, organizations need to simplify processes and systems first — technology won't fix broken foundationsAI can act as an enabler for medical-commercial alignment, but directional clarity on where you're headed has to come firstThe goal hasn't changed: showing up with relevance and trust for HCPs to improve patient outcomesDigitizing what exists today is not the destination — the real question is where pharma needs to be in five to ten years📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk: https://www.linkedin.com/in/andreychuk/
• 
  Breaking Pharma Silos: Strategies for Cross-Functional Success l Pharma Talks 24.06.2026 19min

  In this episode Laragh De Bhulbh shares her expertise on breaking down silos within pharma organizations, fostering cross-functional collaboration, and implementing strategic frameworks to enhance medical affairs. Discover practical tips for leaders and the importance of trust, communication, and strategic alignment in driving patient impact.Key topics:- Cross-functional collaboration challenges in pharma- The Catalyst framework for alignment- Leadership strategies for medical affairs- The role of trust and communicationChapters00:00 Introduction to Laragh De Bhulbh and her expertise01:24 Lara's background and motivation for improving pharma collaboration02:21 The evolution of medical affairs and organizational alignment03:27 Challenges in integrating medical and commercial functions06:10 Overcoming silos: trust, safety, and open communication10:04 The Catalyst framework: eight pillars for cross-functional success12:42 The importance of omnichannel communication and rapid pivoting15:59 Leadership tips for fostering collaboration and strategic clarity17:43 Quick reactions: what is hot or not in pharma collaboration19:18 Final thoughts: clarity and communication as game changersDiscover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/***Follow Viseven, Nataliya, and Laragh in social media:https://www.linkedin.com/company/2907491https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/ldeb/
• 
  Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Michael Kurr 17.06.2026 14min

  In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Michael Kurr, a global transformation leader with 15+ years building large-scale commercial and medical affairs operations at Novartis and Boehringer Ingelheim, on what delivery at scale actually looks like in the AI era.Michael built content and delivery organizations of over 1,000 people — and he has some of the most direct takes on where pharma transformation is stalling.Key takeaways:Modular content served its purpose as a scalability crutch — but well-trained AI models will eventually make it obsoleteMLR is a bottleneck not just because of technology, but because of trust — local approvers carry legal liability and need confidence in what they sign offAI systems must become more explainable and deterministic before pharma can rely on AI-generated and AI-approved contentThe King Kong principle: having content is the easier part — getting the right content to the right customer at the right time, at scale, is the real challengeStaying relevant and staying current is the only viable strategy for individuals navigating AI-driven transformation📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Michael Kurr → https://www.linkedin.com/in/michaelkurr/
• 
  Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Lauren Leahy 05.06.2026 3min

  In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Lauren Leahy, who leads global and international medical capabilities operations, on what AI really means for the people working inside pharma today.Lauren brings a medical affairs perspective to a conversation that's usually dominated by commercial voices.Key takeaways:AI isn't eliminating jobs — but it is fundamentally changing how they're structured and what skills they demandIn omnichannel, AI is actually increasing workload in the short term as teams redesign processes and upskillThe real opportunity isn't just productivity gains — it's system-level change and improved output qualityMedical and commercial functions need to work closer together around a single customer experienceStaying curious and adaptable — at both individual and company level — is the core competency for navigating what's ahead📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
• 
  Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Laetitia Huret 04.06.2026 5min

  In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk sits down with Laetitia Huret, Lead of Transformation at Servier, to explore what AI-driven commercial excellence actually looks like on the ground.Laetitia Huret works across global-to-local transformation, helping teams navigate digital, data, and AI change in the sales and commercial space.Key takeaways:The real question isn't whether AI will replace jobs — it's whether we're willing to keep ways of working that can be replacedAI's value in pharma lies in augmenting HCP engagement, not just accelerating content volumeHuman experience and accumulated knowledge remain the irreplaceable edge in an AI-assisted environmentEmbracing agentic and generative AI tools requires genuine investment in understanding them — not expecting magicThose not actively adopting AI risk falling behind in an industry-wide shift already underway📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
• 
  Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 2 03.06.2026 19min

  Watch the first part of the conversation: https://youtu.be/PtR62juQ4FYThis episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.👥 Guests in this episode:Bruno Senouci - co-CEO at DRCOMGwenael Meneux - co-CEO at DRCOMKey Topics:AI impact on pharma communicationRegional differences in Asia healthcare marketsGlobal to local content adaptation strategiesContact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Follow Viseven and Nataliya, Bruno and Gwenael in social media: https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/bsenouci/https://www.linkedin.com/in/gwenael-meneux/?locale=fr
• 
  Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 1 26.05.2026 19min

  Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQThis episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.👥 Guests in this episode:Bruno Senouci - co-CEO at DRCOMGwenael Meneux - co-CEO at DRCOMKey Topics:AI impact on pharma communicationRegional differences in Asia healthcare marketsGlobal to local content adaptation strategiesFollow Viseven and Nataliya, Bruno and Gwenael in social media: https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/bsenouci/https://www.linkedin.com/in/gwenael-meneux/?locale=fr
• 
  Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Vanitha Venkatasubramaniam 11.05.2026 3min

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Vanitha Venkatasubramaniam, Associate Director at Novo Nordisk, for an honest conversation about where pharma stands today with AI — and where the real opportunity lies ahead.Vanitha brings a refreshingly balanced view: the skills aren't fully there yet, but the intention from leadership is. And the most exciting work? Using AI to genuinely improve the experience for HCPs and patients.Key takeaways:AI adoption in pharma is accelerating faster than most teams are ready forLeadership intent is strong — but building the right skills across teams remains the gapGenerative AI is already embedded in day-to-day workflows — Copilot, emails, meetingsThe biggest opportunity is using AI to enhance experiences for HCPs and patients, not just internal efficiencyThink beyond existing marketing models — combine them with technology to create innovative go-to-market approaches📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
• 
  Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Maryna Alexeychuk 05.05.2026 4min

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice.Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day.Key takeaways:AI should be embedded where marketers already work — content, campaigns, reportingContextual, always-on AI beats standalone tools nobody opens twiceAI won't replace pharma marketers — human context in engagement is irreplaceableBefore choosing a technology, map your end-to-end processes and define your goal first📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
• 
  Pharma Talks Live from Reuters Pharma Barcelona with Marc Koolen 04.05.2026 4min

  In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/marc-koolen/
• 
  Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Haider Alleg 02.05.2026 6min

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that.With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and makes a bold claim: this isn't a technology shift. It's a culture shift.Key takeaways:AI in R&D and manufacturing is already mature — commercial operations are just catching upDark factories and agentic systems show what full automation can look likeThe biggest opportunity isn't automating tasks — it's re-internalizing operational work with AIMedical and scientific affairs are best positioned to lead the way right nowThe advice that matters most: get your hands dirty and stay curious📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect:🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙️ Haider Alleg → https://www.linkedin.com/in/haideralleg/
• 
  Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Yacin Marzouki 30.04.2026 4min

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Yacin Marzouki, Founder and Leader of Beyond Health, to explore how AI is truly reshaping pharma marketing — and why the real transformation goes far deeper than individual pilots or content tools.Key takeaways:- AI in pharma marketing requires systemic thinking, not point solutions- Content without a delivery strategy is content that collects dust- Modular content isn't dead — it's just often implemented too early- Data hygiene and taxonomy are the boring work that makes everything else possible--📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)--🔗 Follow & Connect:🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙 Yacin Marzouki → https://www.linkedin.com/in/yacin-m-customerengagement/
• 
  HCP Engagement in Pharma — Are We Actually Getting Better? l Pharma Talks with Nataliya Andreychuk 22.04.2026 32min

  Pharma has invested heavily in digital, CRM, and omnichannel — and yet the HCP engagement gap persists. In this episode, Nataliya Andreychuk talks with Mark Watson (Fractal Force) about why the problem is structural, not a failure of effort, and what it genuinely takes to close it: from fixing broken feedback loops to defining what "working" actually means at the behaviour level.Key Topics:The gap between digital investment and actual engagement resultsThe importance of foundational architecture in customer engagementThe role of feedback loops in improving HCP interactionsChallenges of content personalization and regulation in pharmaStrategic content design and journey logic in omnichannel marketingChapters00:00 Introduction to Customer Engagement Challenges02:22 Understanding the Gap in Pharma Engagement05:01 The Evolution of Customer Centricity07:56 Architecting Effective Engagement Strategies10:47 Content Creation and Regulatory Challenges13:45 Intelligent Content Design for Better Engagement16:25 Building a Feedback Loop for Success18:01 Making Engagement Real and Effective20:52 Practical Steps for Transformation23:33 Final Thoughts and RecommendationsFollow Nataliya Andreychuk and Mark in social media:https://www.linkedin.com/in/andreychuk/linkedin.com/in/markwatsonuk
• 
  Pharma Talks Live from Philadelphia | AI, Omnichannel & Market Access Disruption 07.04.2026 29min

  In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond.👥 Guests in this episode:Rohit Khuttan — Practice Director, Everest GroupOn AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise mindset is the #1 thing that needs to change.Ruslan Horblyuk — Chief Strategy Officer, AESARAOn AI in market access, health technology assessments, trust in AI data, and whether human-in-the-loop will always be necessary.Nihar Patel — Business Development, Sun PharmaOn generative, predictive and communicative AI, breaking data silos, and the three pharma areas set for the biggest disruption.Key topics covered:Is Omnichannel really a content problem, not a channel problem?How AI is changing content production and the pharma supply chainCan we trust AI data in market access decisions?Will AI replace pharma professionals — or make them smarter?The three pharma disciplines AI will disrupt first📲 Enjoyed this episode?👉 Like, Subscribe & hit the to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at Reuters Pharma Barcelona
• 
  Pharma Talks: Building Trust in Agentic AI in Pharma 27.03.2026 13min

  In this episode of Pharma Talks, Natalyia Andreychuk and Anna Shavurska explore trust in AI, especially agentic AI in pharma, the importance of women in tech, and how AI can be developed responsibly with a focus on safety, trust, and diversity.Takeaways:Trust in agentic AI and safety measures in pharmaThe importance of women in AI development and diversityTechnical approaches to secure and reliable AI, including knowledge bases and retrieval-augmented generationChapters00:00 Introduction to AI Trust and Women in Tech02:00 Understanding Agentic AI and Knowledge Base Security03:45 Ensuring Data Privacy and Trust in Pharma AI05:39 Technical Challenges in Visual and Text Generation07:35 Prompt Engineering and AI Output Precision09:50 The Importance of Women in AI Development11:38 Historical Bias and the Need for Diversity in AI12:39 Inspiration and Career Path in AI13:30 Closing Remarks and Future of Women in AI